Correspondence 0001104659-25-010354 from iBio, Inc. (IBIO)
iBio, Inc.
Date: Feb. 7, 2025 · CIK: 0001420720 · Accession: 0001104659-25-010354
AI Filing Summary & Sentiment
File numbers found in text: 333-284647
Show Raw Text
CORRESP
1
filename1.htm
February 7, 2025
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Dickerson
Re:
iBio, Inc.
Registration Statement on Form S-3
Filed January 31, 2025
File No: 333-284647
Dear Ms. Dickerson:
iBio, Inc. (the “Registrant”)
hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-284647), be accelerated
by the U.S. Securities and Exchange Commission (the “Commission”) to become effective on Monday, February 10, 2025,
at 5:00 p.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Registrant understands
that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities
under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes
Leslie Marlow of Blank Rome LLP to orally modify or withdraw this request for acceleration. Please contact Leslie Marlow at (212) 885-5358
or Melissa Palat Murawsky at (215) 569-5732 with any questions you may have concerning this request, and please notify either of them
when this request for acceleration has been granted.
Very truly yours,
IBIO, INC.
By:
/s/ Marc A. Banjak
Name:
Marc A. Banjak
Title:
Chief Legal Officer
cc: Leslie Marlow, Blank Rome LLP
Melissa Palat Murawsky, Blank Rome LLP